Jamie Geier

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

Stanley Cohen, Yoshiya Tanaka, Xavier Mariette et al. · Annals of the Rheumatic Diseases · 2017 · 395 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

Megan E. B. Clowse, Steven R. Feldman, John D. Isaacs et al. · Drug Safety · 2016 · 147 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry

Joel M. Kremer, Clifton O. Bingham, Laura C. Cappelli et al. · ACR Open Rheumatology · 2021 · 138 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor

Christina Charles‐Schoeman, Pierre Wicker, Miguel Á. González‐Gay et al. · Seminars in Arthritis and Rheumatism · 2016 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Being High and Taking Sexual Risks: Findings from a Multisite Survey of Urban Young Men Who Have Sex With Men

Ann Stueve, Lydia O’Donnell, Richard Durán et al. · AIDS Education and Prevention · 2002 · 115 citations

Public Health, Community Health, Preventive Medicine +17